These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4065210)

  • 1. Relations between muscimol, quinuclidinyl benzilate and nicotine binding sites in brain after very long treatment with ethanol in rats.
    Nordberg A; Wahlström G; Eriksson B
    Eur J Pharmacol; 1985 Sep; 115(2-3):301-4. PubMed ID: 4065210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]muscimol and [3H]quinuclidinyl benzilate binding in rat cortex in the abstinence after long-term barbital treatment.
    Nordberg A; Wahlström G; Eriksson B
    Acta Physiol Scand; 1986 Jan; 126(1):153-6. PubMed ID: 3006433
    [No Abstract]   [Full Text] [Related]  

  • 4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
    Mittal CK
    Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of calcium antagonists on muscarinic receptor subtypes in the rat brain.
    Katayama S; Kito S; Miyoshi R; Matsubayashi H
    Brain Res; 1987 Sep; 422(1):168-71. PubMed ID: 3676778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ethanol and ethanol withdrawal on 3H-muscimol binding and behaviour in the rat: a pilot study.
    Linnoila M; Stowell L; Marangos PJ; Thurman RG
    Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):407-11. PubMed ID: 6285669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
    Marks MJ; Collins AC
    Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in populations of cholinergic binding sites in brain after chronic exposure to barbital in rats.
    Nordberg A; Wahlström G
    Brain Res; 1982 Aug; 246(1):105-12. PubMed ID: 7127080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of [3H]quinuclidinyl benzilate to intestinal mucus. An artifact in identification of epithelial cell muscarinic receptors.
    Rimele TJ; Gaginella TS
    Biochem Pharmacol; 1982 Feb; 31(4):515-20. PubMed ID: 7066020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of muscarinic and nicotinic binding sites in brain.
    Nordberg A; Larsson C
    Acta Physiol Scand Suppl; 1980; 479():19-23. PubMed ID: 6932800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional age-related alterations in cholinergic and GABAergic receptors in the rat brain.
    Araki T; Kato H; Fujiwara T; Itoyama Y
    Mech Ageing Dev; 1996 Jul; 88(1-2):49-60. PubMed ID: 8803921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]quinuclidinyl benzilate to regions of rat pituitary and hypothalamus.
    Hoover DB; Hancock JC; Talley NS
    Brain Res Bull; 1981 Mar; 6(3):209-11. PubMed ID: 7225899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of brain nicotinic receptors by chronic agonist infusion.
    Bhat RV; Turner SL; Selvaag SR; Marks MJ; Collins AC
    J Neurochem; 1991 Jun; 56(6):1932-9. PubMed ID: 2027007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
    J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal function impairment in rabies-infected rat brain.
    Tsiang H
    J Gen Virol; 1982 Aug; 61 (Pt 2)():277-81. PubMed ID: 7119753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.